Guillermo Espino

Statistics

Publications

Citations

804

H-Index

Active since

2013

Affiliations

South Texas Accelerated Research Therapeutics(Current)

Guillermo Espino is an author at South Texas Accelerated Research Therapeutics specializing in pharmacokinetics of anticancer drugs, pharmacology, and pharmacokinetics of anticancer agents.

Publications per year

2013–2015

Publications

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Amita Patnaik, Soonmo Peter Kang, Drew Rasco et al. · Clinical Cancer Research · 2015 · 794 citations

Medicine, Oncology, Pharmacology +17

MLN2480, an investigational oral pan-RAF kinase inhibitor, in patients (pts) with relapsed or refractory solid tumors: Phase I study.

Drew Rasco, Anthony J. Olszanski, Amita Patnaik et al. · Journal of Clinical Oncology · 2013 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

1–2 of 2